Transplants | Company & Drug | Global | 2020
This folder covers DRG’s Company & Drugs (C&D) data for Transplants which include market forecast (US, ROW and Global) and analysis on drug profie, drug group and therapy area.
Related Market Assessment Reports
Report
Kidney Transplant – Current Treatment – Treatment Algorithms: Claims Data Analysis – Kidney Transplant (US)
Each year in the United States, thousands of patients with end-stage renal disease undergo a kidney transplant. To prevent rejection and maintain the new kidney’s functionality, patients must…
Report
Graft Versus Host Disease – Landscape & Forecast – Niche & Rare Disease Landscape & Forecast (US/EU5)
Graft versus host disease (GVHD) is a potentially life-threatening complication of allogenic hematopoietic stem cell transplantation (HSCT). Steroids have been the first-line therapy for the…
Report
Graft Versus Host Disease – Epidemiology – Epidemiology – Graft Versus Host Disease – Emerging Markets
Clarivate Epidemiology’s coverage of graft versus host disease (GVHD) comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets and the emerging…
